Topic: FDA warning letter

Apothecares

API repackager in hot water with FDA

A U.S. API repackager is in hot water with the FDA, earning itself a warning letter by taking liberties with the expiration dates on the drugs it repackages and having a quality unit that pretty much shirked its responsibilities.